November 19, 2024
(Reuters) -Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its […]
November 19, 2024
Which patients with early-stage breast cancer will benefit most from immunotherapy, and at what point is immunotherapy most useful? This question spans neoadjuvant and adjuvant settings. […]
November 19, 2024
VANCOUVER, BRITISH COLUMBIA — Amid a lack of consensus on screening men for prostate cancer using the prostate-specific antigen (PSA), family physicians can consider suggesting that […]
November 18, 2024
The US Food and Drug Administration has approved revumenib (Revuforj — Syndax Pharmaceuticals) for relapsed or refractory acute leukemia with a KMT2A gene translocation in adult […]
November 18, 2024
TOPLINE: Perioperative chemotherapy as well as neoadjuvant chemoradiation therapy followed by surgery (trimodality therapy) are associated with improved overall survival in patients with locally advanced esophageal […]
November 18, 2024
TOPLINE: Statin use during concurrent chemoradiotherapy (CCRT) for advanced nasopharyngeal cancer (NPC) is associated with a 52% reduction in all-cause mortality. Higher cumulative defined daily doses […]
November 18, 2024
Overtreatment of men with prostate cancer and limited life expectancy (LE) has persisted in the era of active surveillance and worsened in some instances, according to […]
November 15, 2024
The European Medicines Agency (EMA) recommended eight medicines for approval this month, including two cancer drugs for treating non-small cell lung cancer (NSCLC). Augtyro for Advanced […]
November 15, 2024
If the name of leukemia specialist Jorge Cortes, MD, appears any more often in PubMed, they’ll need to name a wing after him. Jorge Cortes, MD […]